Correction to "Apoferritin-Encapsulated Jerantinine A for Transferrin Receptor Targeting and Enhanced Selectivity in Breast Cancer Therapy"

Abuzaid H 1 , Abdelrazig S 1 , Ferreira L 2 , Collins HM 1 , Kim DH 1 , Lim KH 3 Show all authors , Kam TS 4 , Thomas NR 2 , Turyanska L 5 , Bradshaw TD 1

Affiliations 

  • 1 School of Pharmacy, Biodiscovery Institute, The University of Nottingham, University Park, Nottingham NG7 2RD, U.K
  • 2 School of Chemistry, Biodiscovery Institute, The University of Nottingham, University Park, Nottingham NG7 2RD, U.K
  • 3 The University of Nottingham Malaysia, Block B, Malaysia Campus, Jalan Broga, 43500 Semenyih, Selangor, Malaysia
  • 4 Department of Chemistry, Faculty of Science, The University of Malaya, 50603 Kuala Lumpur, Malaysia
  • 5 Faculty of Engineering, The University of Nottingham, Additive Manufacturing Building, Jubilee Campus, University Park, Nottingham NG7 2RD, U.K
ACS Omega, 2024 Jan 09;9(1):2012.
PMID: 38222495 DOI: 10.1021/acsomega.3c09291

Abstract

[This corrects the article DOI: 10.1021/acsomega.2c00997.].

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications